Cyril Amarchand Mangaldas advised a middle eastern sovereign fund.
A wholly owned subsidiary of a middle eastern sovereign fund has entered into definitive agreements to invest USD 200 million for an approx. 3% stake in Micro Life Sciences Private Limited (“Company“), one of India’s leading medical devices companies.
The transaction was led by Vandana Sekhri, Partner; with support from Arun Prabhu, Partner (Head – Technology); Poornima Singh, Partner; Radhika Shukla, Senior Associate; Sudarshan Srikanth, Senior Associate;Dhrumil Sanghvi, Senior Associate; and Rishi Rathod, Associate.
With subject matter guidance from Indranil Deshmukh, Partner; Shaneen Parikh, Partner; and Gokul Rajan, Partner.
Due Diligence Team was led by Vandana Sekhri, Partner; with assistance from Siddharth Vedula, Partner;Dhrumil Sanghvi, Senior Associate; Lokit Khurana, Senior Associate; Kabeer Jay, Associate; Bhavya Arya, Associate; Karthik Subramaniam, Associate; and Kanishka Iyer, Associate.
With support from:
Biplab Lenin Partner; Priyam Rajkumar, Senior Associate; Anam Chowdhary, Associate; (on pharma & healthcare regulatory related matters)
Arun Prabhu, Partner (Head – Technology); Nidhi Jhawar, Senior Associate; Kanav Khanna, Associate; Riddhiraj Sehgal, Associate; Mansi Jain, Associate; Rushil Mehta, Associate (on IP/IT/Data Protections related matters)
Bishen Jeswant, Partner; Akash Mishra, Principal Associate; Soumyashree Ray Chowdhury, Senior Associate; Shivika Gupta, Associate; Tara Thakur, Associate; Nilavan S, Associate (on employment related matters)
Competition Law
Kaustav Kundu, Partner; with the support from Vanya Agarwal, Associate; Mohini Parghi, Associate; Vrinda Gundam, Associate; advised on competition law aspects of the transaction.
